Basophils and plasmacytoid dendritic cells are potential sources for error in flow cytometric monitoring of patients receiving anti-CD22 therapies. AKA not all anti-CD22 antibodies are created equal

Malcolm Acon-Laws, Michael Bayerl, Christopher Ehman, Jozef Malysz, Cinda Boyer

Research output: Contribution to journalLetterpeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)891-892
Number of pages2
JournalAmerican Journal of Hematology
Issue number10
StatePublished - Oct 1 2011

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this